Myriad Genetics, Inc. facts

Myriad Genetics is a biopharmaceutical company head-quartered in the University of Utah Research Park in Salt Lake City, Utah. It was co-founded in 1991 by Mark Skolnick and Nobel laureate Dr. Walter Gilbert. The company markets cancer predictive medicine products and develops therapeutics including drug candidates in the areas of Alzheimer's disease and cancer. Myriad Genetics has been referred to as "probably the most hated diagnostics company"... more

Read article at Wikipedia

Also known as:

Myriad Genetics

Business

Address

Myriad Genetics, Inc. Headquarters

Salt Lake City Salt Lake County

United States of America

Revenue:

Currency	Amount	Valid Date
US$	157,100,000	Jun 30, 2007

Operating income:

Currency	Amount	Valid Date
US$	-40,170,000	Jun 30, 2007

Market capitalization:

Currency	Amount	Valid Date
US$	2,100,000,000	Dec 31, 2007

Board members:

View Myriad Genetics, Inc. board members »

Ticker symbol:

Stock exchange	Ticker symbol
NASDAQ	MYGN

Employees and other personnel:

Person	Title
Jerry S Lanchbury	Executive Vice President
Jerry S Lanchbury	Research
Mark H Skolnick	Chief Scientific Officer
Richard M Marsh	Vice President
Richard M Marsh	General Counsel
Jay M Moyes	Chief Financial Officer
William A Hockett III	Vice President
Adrian N Hobden
Peter D Meldrum	President
Peter D Meldrum	Chief Executive Officer

View Myriad Genetics, Inc. employees and other personnel »

top ↑

Facts from the Community

From the BioVenturist base

Technology Focus:

View entire collection »

Medical focus:

View entire collection »

From the business2 base

Revenue:

Currency	Amount	Valid Date
US$	326,530,000	Jun 30, 2009

Operating Income:

Currency	Amount	Valid Date
US$	126,460,000	Jun 30, 2009

Net profit:

Currency	Amount	Valid Date
US$	84,610,000	Jun 30, 2009

Cash:

Currency	Amount	Valid Date
US$	63,510,000	Jun 30, 2009

Current Assets:

Currency	Amount	Valid Date
US$	366,150,000	Jun 30, 2009

Total Assets:

Currency	Amount	Valid Date
US$	466,420,000	Jun 30, 2009

Current Liabilities:

Currency	Amount	Valid Date
US$	32,200,000	Jun 30, 2009

Total Liabilities:

Currency	Amount	Valid Date
US$	32,200,000	Jun 30, 2009

Retained Earnings:

Currency	Amount	Valid Date
US$	-119,940,000	Jun 30, 2009

top ↑

These people have edited this topic:

Metaweb Staff
tristan
- Member Since: Nov 30, 2006
- Contributions: 3,058,401 Facts
jame0taylor
- Member Since: May 20, 2008
- Contributions: 16,115 Facts

Edit this topic

Last edited Dec 1, 2009 See all topic history »

Myriad Genetics, Inc.

Legal structure:

Place founded:

Industry:

Also known as:

Business

Address

Myriad Genetics, Inc. Headquarters

Revenue:

Operating income:

Market capitalization:

Board members:

Ticker symbol:

Employees and other personnel:

Facts from the Community

From the BioVenturist base

Technology Focus:

Medical focus:

From the business2 base

Revenue:

Operating Income:

Net profit:

Cash:

Current Assets:

Total Assets:

Current Liabilities:

Total Liabilities:

Retained Earnings:

These people have edited this topic:

tristan

jame0taylor

Myriad Genetics, Inc. elsewhere on the web

What is Freebase?

Flag this Topic

Why do you want to flag this topic?

Myriad Genetics, Inc.

Legal structure:

Place founded:

Industry:

Also known as:

Business

Address

Myriad Genetics, Inc. Headquarters

Revenue:

Operating income:

Market capitalization:

Board members:

Ticker symbol:

Employees and other personnel:

Facts from the Community

From the BioVenturist base

Technology Focus:

Medical focus:

From the business2 base

Revenue:

Operating Income:

Net profit:

Cash:

Current Assets:

Total Assets:

Current Liabilities:

Total Liabilities:

Retained Earnings:

These people have edited this topic:

tristan

jame0taylor

Related Topics

Myriad Genetics, Inc. elsewhere on the web

What is Freebase?

Flag this Topic

Why do you want to flag this topic?